Cargando…
Variations in MHC class I antigen presentation and immunopeptidome selection pathways
Major histocompatibility class I (MHC-I) proteins mediate immunosurveillance against pathogens and cancers by presenting antigenic or mutated peptides to antigen receptors of CD8+ T cells and by engaging receptors of natural killer (NK) cells. In humans, MHC-I molecules are highly polymorphic. MHC-I...
Autores principales: | Zaitouna, Anita J., Kaur, Amanpreet, Raghavan, Malini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525337/ https://www.ncbi.nlm.nih.gov/pubmed/33014341 http://dx.doi.org/10.12688/f1000research.26935.1 |
Ejemplares similares
-
MHC Class I Immunopeptidome: Past, Present, and Future
por: Yewdell, Jonathan W.
Publicado: (2022) -
Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
por: Leddy, Owen, et al.
Publicado: (2023) -
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022) -
Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP)
por: Geng, Jie, et al.
Publicado: (2018) -
A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018)